Building Immunity for a Healthier World
HIPRA is a biotechnological pharmaceutical company focused on prevention for animal and human health, with a broad range of highly innovative vaccines and an advanced diagnostic service.
A company that works with the latest technological advances to create innovative solutions that improve world health.
R&D projects are the basis of the knowledge. HIPRA has more than 50 years of experience dedicated to the research and development of different vaccines. With a unique organizational model, HIPRA controls all the processes of the value chain, generating singular know-how and becoming a reference in the research, production, and commercialization of biologics.
HIPRA has a solid international presence, commercial subsidiaries and a global distribution network, allowing products to reach costumers from more than 100 countries, covering the 5 continents.
Veterinary Products, Diagnostic service and Diagnostic reagents, Smart Vaccination, Medical Devices for Animal Health, Human Health, One Health, Vaccines, and covid19 vaccine
HIPRA | Building Immunity for a Healthier World
| Entity | Type | Tweets | Articles | |
|---|---|---|---|---|
| Kemchain Software Development, regtech | Other 22 Oct 2025 | | |
| Bulletin of the World Health Organization Book and Periodical Publishing, healthtech | Other 22 Oct 2025 | | |
| Nymi Software Development, it services, consulting, regtech | Other 23 Oct 2025 | | |
| FARMESPAÑA INDUSTRIAL Pharmaceutical Manufacturing | Other 24 Sep 2025 | | |
| Medichem, S.A. Pharmaceutical Manufacturing, deeptech, manufacturing | Other 31 Jul 2025 | | |
| European Aquaculture Society Research Services, deeptech | Other 11 Sep 2025 | | |
| American Association of Avian Pathologists Veterinary Services, healthtech | Other 15 Jul 2025 | | |
| AVEC EU Poultry Food and Beverage Manufacturing, foodtech | Other 15 Jul 2025 | | |
| ISPE Pharmaceutical Manufacturing, edtech | Other 22 Jul 2025 | | |
| Catalonia Trade & Investment Government Administration | Other 16 Jun 2025 | | |